Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000699661 | SCV000828381 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type R18 | 2022-09-08 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the TRAPPC11 mRNA. It is expected to extend the length of the TRAPPC11 protein by 23 additional amino acid residues. This variant is present in population databases (rs142222368, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with TRAPPC11-related conditions. ClinVar contains an entry for this variant (Variation ID: 577012). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Athena Diagnostics | RCV000993347 | SCV001146235 | uncertain significance | not provided | 2019-08-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000993347 | SCV001982352 | uncertain significance | not provided | 2021-09-09 | criteria provided, single submitter | clinical testing | Normal stop codon changed to an Arginine codon, leading to the addition of 23 amino acids at the C-terminus; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV000699661 | SCV003823411 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type R18 | 2022-09-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994087 | SCV004813220 | uncertain significance | not specified | 2024-02-19 | criteria provided, single submitter | clinical testing | Variant summary: TRAPPC11 c.3400T>C (p.X1134ArgextX23) changes the termination codon and is predicted to lead to an extended protein with additional amino acids added to the normal C-terminus. The variant allele was found at a frequency of 0.00021 (i.e. reported in 338 carriers) in 1607074 control chromosomes (gnomAD v4.0). This frequency is not higher than the estimated maximum expected for a pathogenic variant in TRAPPC11 causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (0.00072), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.3400T>C in individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 577012). Based on the evidence outlined above, the variant was classified as uncertain significance. |